The medium in cells treated with phenformin and oxamate. CT26 cells have been treated with the indicated compounds for 1, 2, or three days and after that lactate in the medium (A) or medium pH (B) was determined. P: phenformin 1 mM, O: oxamate 40 mM, PO: phenformin 1 mM+oxamate 40 mM, C: untreated handle. : P,0.05 compared together with the other groups. {: P,0.05 compared with the group C and P. doi:10.1371/journal.pone.0085576.gPLOS ONE | plosone.orgAnti-Cancer Effect of Phenformin and OxamateFigure 4. Complex I inhibition by phenformin. (A) CT26 cells were treated with or without phenformin for 24 hours and then extracts were prepared to measure complex I activity as described in Materials and Methods. The Y axis is of complex I activity when the activity of complex I in the control group is regarded as 100 . (B) Effects of the indicated compounds on oxygen consumption by CT26 cells were determined as an indicator of mitochondrial oxidative metabolism. (C) Cells were treated with or without phenformin in the presence or absence of methyl succinate, which bypasses complex I of the electron transport chain. After 24 hours the number of live cells in the cultures was determined. MS: methyl succinate. C: control, P: phenformin 1 mM, O: oxamate 40 mM, PO: phenformin 1 mM+oxamate 40 Mm. : P,0.05. doi:10.1371/journal.pone.0085576.gadditional targets that influence its ability to work synergistically with phenformin.Effect of Phenformin and Oxamate Combination on ROS, ATP, and DNA DamageInhibition of complex I is expected to increase superoxide production by mitochondria, enhance formation of other ROS, leading to oxidative stress and potential DNA damage. Inhibition of glycolytic and oxidative metabolic pathways is expected to reduce MyD88 manufacturer cellular ATP levels. Such changes may be directly related to the cytotoxicity and synergy of phenformin and oxamate. As indicated by MitoSox Red staining, phenformin induced elevated production of mitochondrial superoxide (Fig. 6A). Oxamate alone did not affect mitochondrial ROS production. However, the addition of oxamate with phenformin greatly potentiated ROS production. NAC is a ROS scavenger that is known to reduce cellular oxidative stress. NAC treatment reduced cell death in phenformin treated cells (Fig. 6B). NAC also reduced cell death in the phenformin plus oxamate treated cells, but was much less effective in this group. Phenformin and oxamate single treatment tended to increase ATP production compared to the control (no statistical differences)(Fig. 6C). However, addition of oxamate plus phenformin greatly decreased ATP levels compared to untreated cells, suggesting a synergistic effect. As a measure of oxidative DNA damage, 8-OHdG in the culture medium, nuclei, or mitochondria was measured. In all three compartments, the phenformin treatment group showed increased DNA damage compared to the control group (Fig. 6D). Oxamate alone showed increased DNA damage in mitochondria compared with the control, when added together with phenformin DNA damage was significantly increased.Death of Cancer Cells occurs through both Apoptotic and PARP-dependent PathwaysWe have previously found that the biguanide metformin kills breast cancer cells through both apoptotic and PARP-dependent pathways [22]. We therefore examined cell death in phenformin and oxamate treated cells in more detail. Cell death was more rapid in the phenformin plus oxamate group than in the phenformin alone group (Fig. 7). In both groups, CDK4 review hallmarks of both apoptos.
